Company: NCEL
Filing Date: 2025-11-06
Form Type: POS AM
Source: 0001213900-25-106799
Chunk: 64

Company: NewcelX Ltd.
Filing Date: 2025-11-06
Form: POS AM
Chunk 64
---
 with a par value of 0.03CHF ($ .03689USD) (the “Preferred Shares”) in connection with the execution of a securities purchase agreement. The Preferred Shares have the following rights, preferences and privileges: •Accrue dividends at an annual rate of eight percent ( 8%) of the stated value of the preferred shares from the date of issuance; •Stated value and initial conversion price of $ 4.96, subject to adjustment, for share splits, dividends and the subsequent sale or issuance of equity and equity -linkedinstruments with an effective price per share that is lower than the initial conversion price (“Down Round Provision”); and •Have no voting rights. Upon any liquidation, dissolution or winding up of the Company, the preferred shareholders will be entitled to receive an amount equal to the stated value of any Preferred Shares held at the time of such an event prior to any holders of common shares. Annex A-14 NLS PHARMACEUTICS LTD.
NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS On November 13, 2024, as disclosed in the Company’s Report on Form 6 -Kfiled with the SEC on November 15, 2024, the Company filed amended and restated articles of association with the commercial registry of the Canton of Zurich, Switzerland, to reflect the following: •Capital increase of CHF 29,887.20through the issuance of 37,359registered common shares with a nominal value of CHF 0.80each. •Conversion of 598,539registered common shares into 598,539registered preferred shares with a nominal value of CHF 0.80each. •Exchange of 207,913registered common shares and 806,452registered preferred shares into 1,014,365non -votingregistered PPCs with a nominal value of CHF 0.03($ .03689USD) each. PPCs have no voting rights and have the same rights, preferences and privileges as the Preferred Shares. Following this transaction, and in connection with the creation of the PPCs, one of the Company’s accredited investors elected to exchange 806,452of its previously held Preferred Shares for an equivalent number of PPCs. This exchange reduced the number of outstanding Preferred Shares accordingly, while increasing the number of outstanding PPCs by the same amount. As a result, there were no Preferred Shares outstanding for U.S. GAAP purposes as of December 31, 202